Regeneron Pharmaceuticals Inc. buy Piper Sandler
Start price
27.01.25
/
50%
€652.60
Target price
27.01.26
€964.27
Performance (%)
-1.93%
End price
28.01.26
€640.00
Summary
This prediction ended on 28.01.26 with a price of €640.00. With a performance of -1.93%, the BUY prediction by Piper_Sandler finished with a loss. Piper_Sandler has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. A total of €3.48 was paid as dividends for this prediction. Piper_Sandler has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -3.315% | -3.315% | 30.989% |
| iShares Core DAX® | 2.554% | -0.112% | 14.995% |
| iShares Nasdaq 100 | 2.742% | -0.470% | 30.954% |
| iShares Nikkei 225® | 6.584% | 3.221% | 49.697% |
| iShares S&P 500 | 1.930% | -0.519% | 24.883% |
Comments by Piper_Sandler for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target lowered by analysts at Piper Sandler from $1,195.00 to $1,013.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€666.40
31.03.26
31.03.26
€762.30
31.03.27
31.03.27
-4.16%
10.04.26
10.04.26
Stopped prediction by Piper_Sandler for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€780.20
01.11.24
01.11.24
€1,099.4
01.11.25
01.11.25
-27.20%
02.11.25
02.11.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1,072.0
23.08.24
23.08.24
€1,109.7
23.08.25
23.08.25
-53.25%
24.08.25
24.08.25